LAS VEGAS, Dec. 8 -- Allscripts Chief Executive Officer Glen Tullman will host a webcast today, broadcasted live from the Allscripts Executive Summit in Las Vegas, to introduce two new innovations: ...
RICHMOND, British Columbia--(BUSINESS WIRE)--KLAS Research named Allscripts (NASDAQ: MDRX) Sunrise™ as 2020 Best in KLAS - Global Acute Care EMR (Canada). Allscripts Sunrise Acute Care is a clinical ...
Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2020 after the close of stock market hours on Thursday, ...
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced a strategic technology partnership with US Orthopedic Alliance (USOA), an orthopedic management services ...
CHICAGO, March 14, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX) announced a strategic partnership with Opargo focused on delivering integrated technology to improve health care efficiency ...
(a) Interest expense and other, net has been adjusted from the amounts presented in the statements of operations in order to remove the amortization of the fair value of the cash conversion option ...
A new service from Allscripts seeks to support physicians’ population health efforts by helping refer patients to clinical trials and reducing the time and costs of trials, bringing treatments to the ...
Allscripts reported revenue lower than Wall Street expectations in the third quarter of $402.1 million, down almost 10% year over year in results released Thursday amid continued pandemic challenges ...
Health IT company Allscripts' data analytics business is ramping up, delivering double-digit gains in the second quarter of 2021. The company's overall revenue was flat for the quarter, with a modest ...
Chicago-based Allscripts made headlines this year amid its COVID-19 response initiatives and its sale of Epsi, the company’s budgeting and analytics business. Here are five of the most-read stories ...
Allscripts Healthcare Solutions, Inc. MDRX is well poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust first-quarter 2021 performance, along ...
Fourth quarter GAAP diluted EPS of $2.14; growth of 11% in non-GAAP diluted EPS to $0.20 Full year 2018 GAAP diluted EPS of $2.04; growth of 16% in non-GAAP diluted EPS to $0.72 Closed sale of ...